Mantzarlis Konstantinos, Deskata Konstantina, Papaspyrou Dimitra, Leontopoulou Vassiliki, Tsolaki Vassiliki, Zakynthinos Epaminondas, Makris Demosthenes
Department of Critical Care, University Hospital of Larissa, School of Medicine, University of Thessaly, 41110 Thessaly, Greece.
Antibiotics (Basel). 2022 Aug 3;11(8):1053. doi: 10.3390/antibiotics11081053.
It is widely known that blood stream infections (BSIs) in critically ill patients may affect mortality, length of stay, or the duration of mechanical ventilation. There is scarce data regarding blood stream infections in mechanically ventilated COVID-19 patients. Preliminary studies report that the number of secondary infections in COVID-9 patients may be higher. This retrospective analysis was conducted to determine the incidence of BSI. Furthermore, risk factors, mortality, and other outcomes were analyzed. The setting was an Intensive Care Unit (ICU) at a University Hospital. Patients suffering from SARS-CoV-2 infection and requiring mechanical ventilation (MV) for >48 h were eligible. The characteristics of patients who presented BSI were compared with those of patients who did not present BSI. Eighty-four patients were included. The incidence of BSI was 57%. In most cases, multidrug-resistant pathogens were isolated. Dyslipidemia was more frequent in the BSI group (p < 0.05). Moreover, BSI-group patients had a longer ICU stay and a longer duration of both mechanical ventilation and sedation (p < 0.05). Deaths were not statistically different between the two groups (73% for BSI and 56% for the non-BSI group, p > 0.05). Compared with non-survivors, survivors had lower baseline APACHE II and SOFA scores, lower D-dimers levels, a higher baseline compliance of the respiratory system, and less frequent heart failure. They received anakinra less frequently and appropriate therapy more often (p < 0.05). The independent risk factor for mortality was the APACHE II score [1.232 (1.017 to 1.493), p = 0.033].
众所周知,重症患者的血流感染(BSIs)可能会影响死亡率、住院时间或机械通气时间。关于机械通气的COVID-19患者血流感染的数据很少。初步研究报告称,COVID-19患者的继发感染数量可能更高。进行这项回顾性分析以确定BSI的发生率。此外,还分析了危险因素、死亡率和其他结果。研究地点是一家大学医院的重症监护病房(ICU)。患有SARS-CoV-2感染且需要机械通气(MV)超过48小时的患者符合条件。将出现BSI的患者特征与未出现BSI的患者特征进行比较。共纳入84例患者。BSI的发生率为57%。在大多数情况下,分离出了多重耐药病原体。血脂异常在BSI组中更常见(p<0.05)。此外,BSI组患者的ICU住院时间更长,机械通气和镇静时间也更长(p<0.05)。两组之间的死亡率没有统计学差异(BSI组为73%,非BSI组为56%,p>0.05)。与非幸存者相比,幸存者的基线APACHE II和SOFA评分较低,D-二聚体水平较低,呼吸系统基线顺应性较高,心力衰竭发生率较低。他们接受阿那白滞素的频率较低,接受适当治疗的频率较高(p<0.05)。死亡率的独立危险因素是APACHE II评分[1.232(1.017至1.493),p=0.033]。